Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9184 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.915 |
High Similarity |
NPD7075 |
Discontinued |
0.9079 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.9034 |
High Similarity |
NPD1549 |
Phase 2 |
0.9013 |
High Similarity |
NPD1934 |
Approved |
0.9007 |
High Similarity |
NPD4380 |
Phase 2 |
0.8986 |
High Similarity |
NPD6799 |
Approved |
0.8966 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8966 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8961 |
High Similarity |
NPD3882 |
Suspended |
0.8954 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8903 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD6599 |
Discontinued |
0.8831 |
High Similarity |
NPD2801 |
Approved |
0.8828 |
High Similarity |
NPD1510 |
Phase 2 |
0.8805 |
High Similarity |
NPD6166 |
Phase 2 |
0.8805 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8805 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8767 |
High Similarity |
NPD2796 |
Approved |
0.8766 |
High Similarity |
NPD6801 |
Discontinued |
0.8742 |
High Similarity |
NPD1512 |
Approved |
0.8681 |
High Similarity |
NPD1240 |
Approved |
0.8675 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8654 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8654 |
High Similarity |
NPD3817 |
Phase 2 |
0.8642 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8609 |
High Similarity |
NPD1511 |
Approved |
0.859 |
High Similarity |
NPD7819 |
Suspended |
0.8581 |
High Similarity |
NPD7411 |
Suspended |
0.8562 |
High Similarity |
NPD1607 |
Approved |
0.8481 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8442 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8438 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8428 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8424 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8418 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8373 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8364 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8344 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8323 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8303 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8289 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8272 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8253 |
Intermediate Similarity |
NPD7472 |
Approved |
0.825 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8224 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8204 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8155 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.811 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8105 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8072 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8041 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7976 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7975 |
Intermediate Similarity |
NPD920 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7961 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7961 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7935 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD943 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7908 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7908 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7905 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7892 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7885 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7882 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7848 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD919 |
Approved |
0.78 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7756 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7742 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7712 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7707 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7682 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7647 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7637 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7637 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7637 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7637 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7637 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7637 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7637 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7613 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7557 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7556 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7547 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7543 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7543 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7541 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7532 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7531 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD9717 |
Approved |
0.75 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7487 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7471 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7471 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7455 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7439 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD3887 |
Approved |
0.743 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7419 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7412 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7384 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD3972 |
Approved |
0.738 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.738 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7363 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7363 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7362 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7354 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7322 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7321 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7315 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7312 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7308 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7301 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7277 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7277 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7262 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.724
|
Intermediate Similarity |
NPD7801 |
Approved |